Literature DB >> 27503167

Development of myotendinous-like junctions that anchor cardiac valves requires fibromodulin and lumican.

Loren E Dupuis1, Lorna Doucette1, A Kittrell Rice1, Ashton E Lancaster1, Matthew G Berger1, Shukti Chakravarti2, Christine B Kern3.   

Abstract

BACKGROUND: There are many patients that exhibit connective tissue related cardiac malformations but do not have mutations in collagen genes. The Small Leucine Rich Proteoglycans (SLRP) fibromodulin (FMOD) and lumican (LUM) bind collagen and regulate fibril assembly in other biological contexts.
RESULTS: FMOD deficient mice and double deficient FMOD; LUM mice exhibited anomalies in regions where cardiac valve tissue interdigitates with adjacent muscle for support. Ectopic connective and/or myocardial tissue(s) was associated with the more severe cardiac valve anomalies in FMOD; LUM deficient mice. At postnatal day 0 (P0) there was an increase in the mesenchymal cell number in the regions where valve cusps anchor in FMOD; LUM deficient mice compared to WT. The cardiac valve anomalies correlated with the highest levels of FMOD expression in the heart and also where myotendinous junctions (MTJ) components biglycan, collagen type I alpha 1, and collagen type VI, are also localized.
CONCLUSIONS: The postnatal assembly of the collagen-rich ECM in regions where cardiac valves anchor, that we have designated 'myotendinous-like junctions' (MTLJ) requires the SLRPs FMOD and LUM. Moreover, FMOD and LUM may facilitate mesenchymal cell differentiation in late stages of cardiac valve development. Developmental Dynamics 245:1029-1042, 2016.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  SLRP; cardiac; collagen; development; extracellular matrix; fibromodulin; lumican; myotendinous junction; valve

Mesh:

Substances:

Year:  2016        PMID: 27503167      PMCID: PMC5026634          DOI: 10.1002/dvdy.24435

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  44 in total

1.  Novel mutations in the small leucine-rich repeat protein/proteoglycan (SLRP) genes in high myopia.

Authors:  Marja Majava; Paul N Bishop; Pasi Hägg; Paul G Scott; Aine Rice; Chris Inglehearn; Christopher J Hammond; Tim D Spector; Leena Ala-Kokko; Minna Männikkö
Journal:  Hum Mutat       Date:  2007-04       Impact factor: 4.878

2.  Genetic evidence for the coordinated regulation of collagen fibrillogenesis in the cornea by decorin and biglycan.

Authors:  Guiyun Zhang; Shoujun Chen; Silvia Goldoni; Bennett W Calder; Holly C Simpson; Rick T Owens; David J McQuillan; Marian F Young; Renato V Iozzo; David E Birk
Journal:  J Biol Chem       Date:  2009-01-09       Impact factor: 5.157

3.  Mutations in KERA, encoding keratocan, cause cornea plana.

Authors:  N S Pellegata; J L Dieguez-Lucena; T Joensuu; S Lau; K T Montgomery; R Krahe; T Kivelä; R Kucherlapati; H Forsius; A de la Chapelle
Journal:  Nat Genet       Date:  2000-05       Impact factor: 38.330

4.  Lumican is increased in experimental and clinical heart failure, and its production by cardiac fibroblasts is induced by mechanical and proinflammatory stimuli.

Authors:  Kristin V T Engebretsen; Ida G Lunde; Mari E Strand; Anne Waehre; Ivar Sjaastad; Henriette S Marstein; Biljana Skrbic; Christen P Dahl; Erik T Askevold; Geir Christensen; Johannes L Bjørnstad; Theis Tønnessen
Journal:  FEBS J       Date:  2013-04-02       Impact factor: 5.542

Review 5.  The regulatory roles of small leucine-rich proteoglycans in extracellular matrix assembly.

Authors:  Shoujun Chen; David E Birk
Journal:  FEBS J       Date:  2013-02-14       Impact factor: 5.542

Review 6.  Tumor microenvironment: Modulation by decorin and related molecules harboring leucine-rich tandem motifs.

Authors:  Silvia Goldoni; Renato V Iozzo
Journal:  Int J Cancer       Date:  2008-12-01       Impact factor: 7.396

Review 7.  Mice deficient in small leucine-rich proteoglycans: novel in vivo models for osteoporosis, osteoarthritis, Ehlers-Danlos syndrome, muscular dystrophy, and corneal diseases.

Authors:  Laurent Ameye; Marian F Young
Journal:  Glycobiology       Date:  2002-09       Impact factor: 4.313

8.  Small leucine-rich proteoglycans exhibit unique spatiotemporal expression profiles during cardiac valve development.

Authors:  Loren E Dupuis; Christine B Kern
Journal:  Dev Dyn       Date:  2014-01-04       Impact factor: 3.780

9.  Fibromodulin regulates collagen fibrillogenesis during peripheral corneal development.

Authors:  Shoujun Chen; Ake Oldberg; Shukti Chakravarti; David E Birk
Journal:  Dev Dyn       Date:  2010-03       Impact factor: 3.780

10.  Proteomic analysis of laser capture microscopy purified myotendinous junction regions from muscle sections.

Authors:  Tugba Can; Laura Faas; David A Ashford; Adam Dowle; Jerry Thomas; Peter O'Toole; Gonzalo Blanco
Journal:  Proteome Sci       Date:  2014-05-07       Impact factor: 2.480

View more
  3 in total

1.  The extracellular matrix proteoglycan lumican improves survival and counteracts cardiac dilatation and failure in mice subjected to pressure overload.

Authors:  Naiyereh Mohammadzadeh; Ida G Lunde; Kine Andenæs; Mari E Strand; Jan Magnus Aronsen; Biljana Skrbic; Henriette S Marstein; Caroline Bandlien; Ståle Nygård; Joshua Gorham; Ivar Sjaastad; Shukti Chakravarti; Geir Christensen; Kristin V T Engebretsen; Theis Tønnessen
Journal:  Sci Rep       Date:  2019-06-24       Impact factor: 4.379

2.  Investigating the role of super-enhancer RNAs underlying embryonic stem cell differentiation.

Authors:  Hao-Chun Chang; Hsuan-Cheng Huang; Hsueh-Fen Juan; Chia-Lang Hsu
Journal:  BMC Genomics       Date:  2019-12-30       Impact factor: 3.969

3.  Lumican promotes joint fibrosis through TGF-β signaling.

Authors:  Dahai Xiao; Tangzhao Liang; Ze Zhuang; Ronghan He; Jianhua Ren; Shihai Jiang; Lei Zhu; Kun Wang; Dehai Shi
Journal:  FEBS Open Bio       Date:  2020-10-25       Impact factor: 2.792

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.